Digilib Perpustakaan Universitas Riau

  • Beranda
  • Informasi
  • Berita
  • Bantuan
  • Pustakawan
  • Pilih Bahasa :
    Bahasa Arab Bahasa Bengal Bahasa Brazil Portugis Bahasa Inggris Bahasa Spanyol Bahasa Jerman Bahasa Indonesia Bahasa Jepang Bahasa Melayu Bahasa Persia Bahasa Rusia Bahasa Thailand Bahasa Turki Bahasa Urdu

Pencarian berdasarkan :

SEMUA Pengarang Subjek ISBN/ISSN Pencarian Spesifik

Pencarian terakhir:

{{tmpObj[k].text}}
Image of Gambaran Pasien Yang Mendapatkan Targeted Therapy Pada Adenokarsinoma Paru Di Rsud Arifin Achmad Provinsi Riau Tahun 2015-2018
Penanda Bagikan

CD Skripsi

Gambaran Pasien Yang Mendapatkan Targeted Therapy Pada Adenokarsinoma Paru Di Rsud Arifin Achmad Provinsi Riau Tahun 2015-2018

MEGA ORCEKA DEPERA SENJA BELANTARA / 1608154083 - Nama Orang;

Lung Adenocarcinoma is a lung cancer that has a characteristic peripheral lesions with glandular formation. The incidence of adenocarcinoma is 40% of all lung cancer cases. Anti-cancer therapy that currently developing is targeted therapy. This therapy aims a specific targets, specific genes or certain proteins on the tumor cells. In Arifin Achmad regional hospital (RSUD Arifin Achmad) of Riau province, the usage of targeted therapy began from 2015, which is relatively new. This study aims to decide the description of patients who get targeted therapy in lung adenocarcinoma in Arifin achmad regional hospital of riau province in 2015-2018. This research is a retrospective descriptive study. The results showed that the characteristics of the lung Adenocarcinoma patients were mostly male (64.7%) and aged >40 years (90,6%). The number of lung adenocarcinoma patients with Epidermal Growth Factor Receptor (EGFR) gene mutation test was 89 patients out of 170 patients. Samples for the EGFR gene mutation test were widely extracted from pleural fluid (39,3%). lung adenocarcinoma patients with positive EGFR mutation test (31,5%) mostly had mutations in exon 19 (20,2%). The number of cases that given the targeted therapy in the form of EGFR-Tyrosin Kinase Inhibitor (EGFR- TKIs) were 25 people (89.3%) with the most type of EGFR-TKIs was gefitinib (16 people, 64%). The conclusion of this research is the location of EGFR mutation in lung adenocarcinoma found in exon 19 and gefitinib was the most widely administered type of targeted therapy.
Keyword: Lung adenocarcinoma, EGFR mutation, targeted therapy


Ketersediaan
#
Perpustakaan Universitas Riau 08 01.120 (0061)
08 01.120 (0061)
Tersedia
Informasi Detail
Judul Seri
-
No. Panggil
08 01.120 (0061)
Penerbit
Pekanbaru : Universitas Riau – Kedokteran – Pendidikan Dokter., 2020
Deskripsi Fisik
xvi, 59 hlm.: ill.: 29 cm
Bahasa
Indonesia
ISBN/ISSN
-
Klasifikasi
08 01.120 (0061)
Tipe Isi
-
Tipe Media
-
Tipe Pembawa
-
Edisi
-
Subjek
PENDIDIKAN DOKTER
Info Detail Spesifik
-
Pernyataan Tanggungjawab
ELFITRA
Versi lain/terkait

Tidak tersedia versi lain

Lampiran Berkas
  • JUDUL
  • DAFTAR ISI
  • ABSTRAK
  • BAB I PENDAHULUAN
  • BAB II TINJAUAN PUSTAKA
  • BAB III METODE PENELITIAN
  • BAB IV HASIL PENELITIAN
  • BAB V PEMBAHASAN
  • BAB VI KESIMPULAN DAN SARAN
  • DAFTAR PUSTAKA
  • LAMPIRAN
Komentar

Anda harus masuk sebelum memberikan komentar

Digilib Perpustakaan Universitas Riau
  • Informasi
  • Layanan
  • Pustakawan
  • Area Anggota

Tentang Kami

As a complete Library Management System, SLiMS (Senayan Library Management System) has many features that will help libraries and librarians to do their job easily and quickly. Follow this link to show some features provided by SLiMS.

Cari

masukkan satu atau lebih kata kunci dari judul, pengarang, atau subjek

Donasi untuk SLiMS Kontribusi untuk SLiMS?

© 2026 — Senayan Developer Community

Ditenagai oleh SLiMS
Pilih subjek yang menarik bagi Anda
  • Karya Umum
  • Filsafat
  • Agama
  • Ilmu-ilmu Sosial
  • Bahasa
  • Ilmu-ilmu Murni
  • Ilmu-ilmu Terapan
  • Kesenian, Hiburan, dan Olahraga
  • Kesusastraan
  • Geografi dan Sejarah
Icons made by Freepik from www.flaticon.com
Pencarian Spesifik
Kemana ingin Anda bagikan?